Inhibitory effect of bFGF on endochondral heterotopic ossification

被引:39
作者
Sakano, S
Hasegawa, Y
Murata, Y
Ito, T
Genda, E
Iwata, H
Ishiguro, N
Seo, H
机构
[1] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Environm Med Res Inst, Dept Teratol & Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ, Environm Med Res Inst, Dept Endocrinol & Metab, Chikusa Ku, Nagoya, Aichi 4648601, Japan
关键词
basic fibroblast growth factor (bFGF); endochondral ossification; bone matrix powder;
D O I
10.1016/S0006-291X(02)00273-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Basic fibroblast growth factor (bFGF) is reported to stimulate repair of fracture and bony defects in in vivo animal studies. However. most studies performed in vitro demonstrate inhibitory effect of bFGF on cartilage and bone differentiation. To understand the discrepancy observed in in vivo and in vitro studies, we evaluated the effect of bFGF on chondro-osteogenesis initiated by bone matrix powder (NIP). MP was implanted in the murine hamstring muscles with or without administration of bFGF. Injection of 1 mug of bFGF markedly reduced the size of heterotopic bone induced by NIP, as detected by X-ray. Injection of 10 mug of bFGF completely inhibited ossification and only fibrous tissues were observed at the site of MP implantation. The expressions of alkaline phosphatase and osteocalcin mRNAs, markers for bone differentiation, were completely suppressed by 10 mug of bFGF. These results demonstrate the inhibitory effect of bFGF on endochondral ossification in vivo, implicating a precaution for its use in musculo-skeletal disorders. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:680 / 685
页数:6
相关论文
共 39 条
[1]
Andreshak JL, 1997, ANAT RECORD, V248, P198, DOI 10.1002/(SICI)1097-0185(199706)248:2<198::AID-AR6>3.0.CO
[2]
2-P
[3]
Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit [J].
Bland, YS ;
Critchlow, MA ;
Ashhurst, DE .
ACTA ORTHOPAEDICA SCANDINAVICA, 1995, 66 (06) :543-548
[4]
EFFECTS OF BASIC FIBROBLAST GROWTH-FACTOR ON BONE-FORMATION INVITRO [J].
CANALIS, E ;
CENTRELLA, M ;
MCCARTHY, T .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05) :1572-1577
[5]
IDENTIFICATION OF TRANSFORMING GROWTH-FACTOR-BETA FAMILY MEMBERS PRESENT IN BONE-INDUCTIVE PROTEIN PURIFIED FROM BOVINE BONE [J].
CELESTE, AJ ;
IANNAZZI, JA ;
TAYLOR, RC ;
HEWICK, RM ;
ROSEN, V ;
WANG, EA ;
WOZNEY, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9843-9847
[6]
ISOLATION OF THE HUMAN-GENE FOR BONE GLA PROTEIN UTILIZING MOUSE AND RAT CDNA CLONES [J].
CELESTE, AJ ;
ROSEN, V ;
BUECKER, JL ;
KRIZ, R ;
WANG, EA ;
WOZNEY, JM .
EMBO JOURNAL, 1986, 5 (08) :1885-1890
[7]
SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]
Delany AM, 1998, AM J PHYSIOL, V274, P734
[9]
INVITRO INSULIN-LIKE GROWTH FACTOR-I INTERACTION WITH CARTILAGE CELLS DERIVED FROM POSTNATAL ANIMALS [J].
DEMARQUAY, D ;
DUMONTIER, MF ;
TSAGRIS, L ;
BOURGUIGNON, J ;
NATAF, V ;
CORVOL, MT .
HORMONE RESEARCH, 1990, 33 (2-4) :111-115
[10]
Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921